Home / Our team / Dr Annet Nakaganda
Leadership
Dr Annet Nakaganda
Founder · Director of Research, Innovation & Education
Also on the team as Clinical officer & cancer epidemiologist (Our researchers)
Dr. Annet is a cancer epidemiologist who created and established the organization. She conceived the idea, developed the vision and mission, and took the necessary steps to bring the organization into existence in order to fight cancer through research and the law. She leads and manages the research and innovation activities within the organization by developing and implementing a strategic research plan aligned with the organization's goals and objectives, Identifying and securing funding sources for research projects, including grants, contracts, partnerships, and internal budgets, managing the team of researchers, scientists, and innovators. She oversees the planning, execution, and completion of research projects and ensures that research and innovation activities meet high-quality standards and adhere to ethical guidelines and regulatory requirements.She also advocates for policies and regulations that support research and innovation.
Dr. Annet Nakaganda, is a Clinical Officer and a Cancer Epidemiologist with expertise in conducting clinical trials and epidemiological research for cancer control. She holds a Ph.D. in medicine, a Master’s degree in public Health (with Distinction) from the University of Manchester United Kingdom, and a BSc. in Psychology from Makerere University Kampala. Dr. Nakaganda has been involved in clinical research for over 20 years now, holding numerous positions such as principal investigator, research clinician; research coordination; research governance, and research monitoring/auditing. Dr. Nakaganda's clinical research career began in the early 2000s, with clinical trials aiming at HIV Prevention of mother-child transmission (PMTCT). This research includes the seminal HIV Network for Prevention Trials (HIVNET) trial number 012, which resulted in the widespread adoption of single-dose Nevirapine, an effective, low-cost PMTCT strategy at the time. She later transitioned to cancer research, helping to establish the Uganda Cancer Institute’s Research and Training Directorate as well as the Cancer Epidemiology and Clinical Trials Unit. She has also worked to build the Uganda National Cancer Control Programme (NCCP) and led the harmonization of East African cancer registration guidelines and procedures. Also, Annet has extensive international exposure and has worked at the NHS Manchester Royal Infirmary Hospital on COVID-19 trials and Heamato-oncology clinical trials including CAR T-Cell therapy clinical trials.
Dr. Nakaganda is also interested in higher education curriculum and pedagogy and has training and experience teaching at the university level. She began her teaching career in 2016 as a Teaching Associate (TA) at The University of Manchester's Masters of Public Health Program(MPH) and at the BSc. Biomedical science course, Biochemistry of Disease unit. Also, Annet supported the design and development of The University of Manchester's BSc. in Public Health course. She is presently a subject matter expert (SME) and lecturer on the MSc. Clinical Research and MSc. Public Health and Health Promotion curricula at the iHeed-University of Warwick. She also teaches Research Ethics and Good Clinical Practice and has taught over 600 researchers in Research Ethics through around 50 in-country training. Annet has received numerous accolades and has been published in peer-reviewed international journals and conferences.
Her recent and ongoing work focuses on expanding best practices for cancer research and control and exploring novel approaches for accelerating the timely availability/utilization of locally generated evidence/data to direct cancer control efforts in low-resource settings. Her specialties include:




